Yvonne E. Thomassen

Inactivated polio vaccine development for technology transfer using attenuated Sabin poliovirus strains to shift from Salk-IPV to Sabin-IPV

Wilfried A.M. Bakker, Yvonne E. Thomassen, Aart G. van’t Oever et al. · Vaccine · 2011 · 96 citations

Veterinary Medicine, Immunology, Infectious Diseases +16

Large-scale production of VHH antibody fragments by Saccharomyces cerevisiae

Yvonne E. Thomassen, Wilmar Meijer, Laurens Sierkstra et al. · Enzyme and Microbial Technology · 2002 · 56 citations

Pharmacy, Immunology, Molecular Biology +16

Next Generation Inactivated Polio Vaccine Manufacturing to Support Post Polio-Eradication Biosafety Goals

Yvonne E. Thomassen, Aart G. van ’t Oever, Monique G.C.T. van Oijen et al. · PLoS ONE · 2013 · 53 citations · Full text

Veterinary Medicine, Biotechnology, Infectious Diseases +17

Multivariate data analysis on historical IPV production data for better process understanding and future improvements

Yvonne E. Thomassen, Eric N.M. van Sprang, Leo A. van der Pol et al. · Biotechnology and Bioengineering · 2010 · 45 citations · Full text

Engineering, Manufacturing Engineering, Operations Management +17

Improved poliovirus d-antigen yields by application of different Vero cell cultivation methods

Yvonne E. Thomassen, Olaf Rubingh, René H. Wijffels et al. · Vaccine · 2014 · 42 citations · Full text

Life Sciences, Biotechnology, Microbiology +17